The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors.

Childhood neuroblastoma is often a fatal disease. A new approach using a combination of two drugs shows promise in reducing ...

Adcendo, a biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal growth factor receptor 2 (HER2) biparatopic antibody-drug conjugate (ADC), ...